Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

272 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Validation of the Valve Academic Research Consortium Bleeding Definition in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation.
Stortecky S, Stefanini GG, Pilgrim T, Heg D, Praz F, Luterbacher F, Piccolo R, Khattab AA, Räber L, Langhammer B, Huber C, Meier B, Jüni P, Wenaweser P, Windecker S. Stortecky S, et al. Among authors: piccolo r. J Am Heart Assoc. 2015 Sep 25;4(10):e002135. doi: 10.1161/JAHA.115.002135. J Am Heart Assoc. 2015. PMID: 26408014 Free PMC article.
Comparative Effectiveness and Safety of New-Generation Versus Early-Generation Drug-Eluting Stents According to Complexity of Coronary Artery Disease: A Patient-Level Pooled Analysis of 6,081 Patients.
Piccolo R, Pilgrim T, Heg D, Franzone A, Rat-Wirtzler J, Räber L, Silber S, Serruys PW, Jüni P, Windecker S. Piccolo R, et al. JACC Cardiovasc Interv. 2015 Nov;8(13):1657-66. doi: 10.1016/j.jcin.2015.08.013. JACC Cardiovasc Interv. 2015. PMID: 26585615 Free article.
Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents for primary percutaneous coronary revascularisation of acute myocardial infarction.
Pilgrim T, Piccolo R, Heg D, Roffi M, Tüller D, Vuilliomenet A, Muller O, Cook S, Weilenmann D, Kaiser C, Jamshidi P, Khattab AA, Taniwaki M, Rigamonti F, Nietlispach F, Blöchlinger S, Wenaweser P, Jüni P, Windecker S. Pilgrim T, et al. Among authors: piccolo r. EuroIntervention. 2016 Dec 10;12(11):e1343-e1354. doi: 10.4244/EIJY15M12_09. EuroIntervention. 2016. PMID: 26690319 Free article. Clinical Trial.
Impact of Diabetic Status on Outcomes After Revascularization With Drug-Eluting Stents in Relation to Coronary Artery Disease Complexity: Patient-Level Pooled Analysis of 6081 Patients.
Koskinas KC, Siontis GC, Piccolo R, Franzone A, Haynes A, Rat-Wirtzler J, Silber S, Serruys PW, Pilgrim T, Räber L, Heg D, Jüni P, Windecker S. Koskinas KC, et al. Among authors: piccolo r. Circ Cardiovasc Interv. 2016 Feb;9(2):e003255. doi: 10.1161/CIRCINTERVENTIONS.115.003255. Circ Cardiovasc Interv. 2016. PMID: 26823484 Clinical Trial.
Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Stent Versus Durable-Polymer Everolimus-Eluting Stent for Percutaneous Coronary Revascularization: 2-Year Results of the BIOSCIENCE Trial.
Zbinden R, Piccolo R, Heg D, Roffi M, Kurz DJ, Muller O, Vuilliomenet A, Cook S, Weilenmann D, Kaiser C, Jamshidi P, Franzone A, Eberli F, Jüni P, Windecker S, Pilgrim T. Zbinden R, et al. Among authors: piccolo r. J Am Heart Assoc. 2016 Mar 15;5(3):e003255. doi: 10.1161/JAHA.116.003255. J Am Heart Assoc. 2016. PMID: 26979080 Free PMC article. Clinical Trial.
External validity of the "all-comers" design: insights from the BIOSCIENCE trial.
Franzone A, Heg D, Räber L, Valgimigli M, Piccolo R, Zanchin T, Yamaji K, Stortecky S, Blöchlinger S, Hunziker L, Praz F, Jüni P, Windecker S, Pilgrim T. Franzone A, et al. Among authors: piccolo r. Clin Res Cardiol. 2016 Sep;105(9):744-54. doi: 10.1007/s00392-016-0983-z. Epub 2016 Apr 1. Clin Res Cardiol. 2016. PMID: 27033859 Free article. Clinical Trial.
272 results